Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate ...
FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...